Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$34.51
+0.3%
$32.62
$27.07
$40.28
$1.40B1.36256,626 shs237,387 shs
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.35
+3.9%
$16.45
$9.56
$22.46
$1.70B1.241.87 million shs2.60 million shs
Liquidia Co. stock logo
LQDA
Liquidia
$14.09
-0.1%
$15.20
$8.26
$19.41
$1.20B0.041.20 million shs1.43 million shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$11.09
+0.2%
$12.87
$5.45
$18.98
$363.74M2.03169,025 shs201,373 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+0.14%-1.63%-1.78%+6.51%+5.21%
National Vision Holdings, Inc. stock logo
EYE
National Vision
+3.91%+6.38%+16.29%+85.02%+66.42%
Liquidia Co. stock logo
LQDA
Liquidia
-0.07%-21.81%-25.37%-4.41%+8.89%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
+0.18%-14.23%-36.59%-2.72%+71.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.6179 of 5 stars
1.33.02.50.02.43.31.9
National Vision Holdings, Inc. stock logo
EYE
National Vision
3.1569 of 5 stars
2.24.00.03.32.90.80.0
Liquidia Co. stock logo
LQDA
Liquidia
3.7163 of 5 stars
4.51.00.00.03.14.20.6
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.75 of 5 stars
3.45.00.00.02.54.20.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.50
Moderate Buy$37.508.67% Upside
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.44
Hold$17.75-20.58% Downside
Liquidia Co. stock logo
LQDA
Liquidia
3.00
Buy$26.8990.84% Upside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$15.5039.77% Upside

Current Analyst Ratings Breakdown

Latest NPCE, EYE, LQDA, and CDRE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $38.00
6/12/2025
Liquidia Co. stock logo
LQDA
Liquidia
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$23.00 ➝ $25.00
6/11/2025
Liquidia Co. stock logo
LQDA
Liquidia
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$25.00 ➝ $23.00
6/2/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$36.00 ➝ $37.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$20.00 ➝ $23.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00
5/28/2025
Liquidia Co. stock logo
LQDA
Liquidia
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $35.00
5/28/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$18.00
5/27/2025
Liquidia Co. stock logo
LQDA
Liquidia
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$559.81M2.51$1.51 per share22.89$5.25 per share6.57
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.85B0.95$3.18 per share7.03$10.60 per share2.11
Liquidia Co. stock logo
LQDA
Liquidia
$14.14M85.16N/AN/A$0.73 per share19.30
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$84.31M4.31N/AN/A$0.79 per share14.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.64M$0.9541.5825.371.586.34%12.88%6.06%8/8/2025 (Estimated)
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$65.90M-$0.33N/A82.783.27-0.81%3.52%1.39%8/6/2025 (Estimated)
Liquidia Co. stock logo
LQDA
Liquidia
-$78.50M-$1.58N/AN/AN/A-765.38%-163.21%-67.14%8/6/2025 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$32.96M-$0.84N/AN/AN/A-36.74%-205.41%-28.29%8/12/2025 (Estimated)

Latest NPCE, EYE, LQDA, and CDRE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million
5/8/2025Q1 2025
Liquidia Co. stock logo
LQDA
Liquidia
-$0.42-$0.45-$0.03-$0.45$3.23 million$3.12 million
5/7/2025Q1 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.32$0.34+$0.02$0.18$510.30 million$510.32 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
3/19/2025Q4 2024
Liquidia Co. stock logo
LQDA
Liquidia
-$0.38-$0.46-$0.08-$0.46$4.60 million$2.92 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.10%N/A40.00%2 Years
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Liquidia Co. stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A

Latest NPCE, EYE, LQDA, and CDRE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.65
3.01
1.96
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.30
0.57
0.37
Liquidia Co. stock logo
LQDA
Liquidia
N/A
6.33
6.33
NeuroPace, Inc. stock logo
NPCE
NeuroPace
6.03
5.59
4.77

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Liquidia Co. stock logo
LQDA
Liquidia
64.54%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
Liquidia Co. stock logo
LQDA
Liquidia
26.50%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,24040.66 million25.58 millionOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
14,00079.05 million76.94 millionOptionable
Liquidia Co. stock logo
LQDA
Liquidia
5085.49 million59.16 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.80 million23.22 millionOptionable

Recent News About These Companies

Cantor Fitzgerald Weighs in on NeuroPace FY2026 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cadre stock logo

Cadre NYSE:CDRE

$34.51 +0.11 (+0.31%)
Closing price 06/16/2025 03:58 PM Eastern
Extended Trading
$34.28 -0.23 (-0.66%)
As of 06/16/2025 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

National Vision stock logo

National Vision NASDAQ:EYE

$22.35 +0.84 (+3.91%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$21.98 -0.37 (-1.67%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Liquidia stock logo

Liquidia NASDAQ:LQDA

$14.09 -0.01 (-0.07%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$14.06 -0.03 (-0.18%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$11.09 +0.02 (+0.18%)
Closing price 06/16/2025 04:00 PM Eastern
Extended Trading
$11.09 0.00 (0.00%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.